Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_provenance.
- NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_assertion description "[With the availability of molecular monitoring of BCR-ABL1 and the use of tyrosine kinase inhibitors, treatment in chronic myeloid leukemia (CML) is now molecularly focused.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_provenance.
- NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_assertion evidence source_evidence_literature NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_provenance.
- NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_assertion SIO_000772 22183070 NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_provenance.
- NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_assertion wasDerivedFrom befree-2016 NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_provenance.
- NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_assertion wasGeneratedBy ECO_0000203 NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_provenance.
- befree-2016 importedOn "2016-02-19" NP947918.RAC5gF0AWkspADhVWOcI7YuZHYATjcdeQ0auajSenomek130_provenance.